Effectiveness and Safety of Botulinum Toxin Type A in Children with Musculoskeletal Conditions: What Is the Current State of Evidence?

• Egile Nagusiak: Noémi Dahan-Oliel (Egilea), Bahar Kasaai (Egilea), Kathleen Montpetit (Egilea), Reggie Hamdy (Egilea)
• Formatua: Liburua
• Argitaratua: Hindawi Limited, 2012-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Children with musculoskeletal conditions experience muscle weakness, difficulty walking and limitations in physical activities. Standard treatment includes physiotherapy, casting, and surgery. The use of botulinum toxins appears as a promising treatment on its own, but usually as an adjunct to other...